NEW YORK (GenomeWeb News) — Allegro Diagnostics, which plans to commercialize molecular diagnostic products for lung cancer, has raised $4 million in a Series A financing.
 
The funding round was led by Kodiak Venture Partners and included investments by Catalyst Health Ventures and Boston University.
 
The startup company’s first commercial product will be a gene-expression based test for early-stage lung cancer.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.